High Precision Medical Imaging Health Checkup (B)

US$4,655
NT$149,435 · you pay the hospital in NT$
Book this checkup

Prefer to book it yourself? Call Beitou Health Management Hospital on 0800-015-104 or use its website ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-20

An executive-tier program with Brain MR angiography, Abdominal MRI / MRCP, Brain MRI, Breast MRI and Pelvic MRI and a 73-test panel, with a doctor's review at the end.

Takes
2 days, overnight
Sedation
Available
Bowel prep
Required
English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Brain MR angiography

Aneurysms and narrowed brain arteries.

Abdominal MRI / MRCP

Liver, pancreas and bile duct tumors and disease.

Brain MRI

Brain tumors, small strokes, aneurysms and early degeneration.

Breast MRI

Breast cancer in high-risk women.

Every test, in English

73 tests listed, 66 of them on our shared test list, so they line up against other hospitals' packages.

Vitals1
Blood Count1
Liver Function9
Kidney & Electrolytes4
Lipids & Cardiometabolic6
Glucose3
Thyroid & Endocrine6
Tumor Markers5
Infection Serology3
Urine & Stool1
Cardiac1
Pulmonary1
Ultrasound6
CT Imaging2
MRI Imaging6
Endoscopy3
Women's Health1
Bone & Body Composition1
Eye1
ENT & Dental2
Neuro & Cognitive1
Consultation2
Show all 73 tests and what each screens for
TestScreens for
Vitals
Body composition analysisBody fat, muscle mass and water percentage.
Blood Count
Complete blood countAnemia, infection and blood cell disorders.
Liver Function
AlbuminLiver function and nutrition status.
Alkaline phosphataseLiver, bile duct and bone conditions.
ALT (SGPT)Liver cell damage; the most common liver screening test.
AST (SGOT)Liver cell damage.
Direct bilirubinBile duct obstruction.
Gamma-GTBile duct and alcohol-related liver stress.
Globulin and A/G ratioImmune protein levels.
LipasePancreatic enzyme; more specific than amylase for pancreatitis.
Total bilirubinJaundice, liver and bile problems.
Kidney & Electrolytes
Blood urea nitrogenKidney function.
CreatinineKidney function.
Estimated GFRKidney filtering capacity; stages chronic kidney disease.
Uric acidGout risk and kidney stone risk.
Lipids & Cardiometabolic
Total cholesterol / HDL ratioA calculated ratio of total cholesterol to HDL cholesterol used in some cardiovascular risk calculators.
HDL cholesterolProtective cholesterol level.
High-sensitivity CRPInflammation linked to heart disease risk.
LDL cholesterolThe main cholesterol driving heart disease risk.
Total cholesterolCardiovascular risk.
TriglyceridesCardiovascular and pancreatitis risk.
Glucose
Fasting glucoseDiabetes and prediabetes.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.
Fasting insulinInsulin resistance.
Thyroid & Endocrine
DHEA-SAdrenal androgen level.
Female hormone panel (FSH, LH, E2)Menopause status and hormone balance.
Free T4Thyroid hormone level.
TestosteroneMale hormone level; low testosterone.
TSHThyroid function; the primary thyroid screening test.
Vitamin D (25-OH)Vitamin D deficiency; bone health.
Tumor Markers
AFPLiver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125Ovarian cancer marker.
CA 19-9Pancreatic and biliary cancer marker.
CEAColorectal and other GI cancer marker.
PSAProstate cancer marker.
Infection Serology
Hepatitis B surface antibodyImmunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibodyHepatitis C infection.
Hepatitis B surface antigenCurrent hepatitis B infection; very common in Taiwan.
Urine & Stool
UrinalysisKidney disease, urinary infection, diabetes.
Cardiac
Resting ECGHeart rhythm and signs of prior heart damage.
Pulmonary
Lung function testAsthma, COPD and lung capacity.
Ultrasound
Abdominal ultrasoundLiver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasoundBreast lumps; complements mammography, especially in dense breasts.
Carotid ultrasoundPlaque in the neck arteries; stroke risk.
Liver elastography (FibroScan)Liver scarring and fat without a biopsy.
Pelvic (gynecologic) ultrasoundUterus and ovary abnormalities (fibroids, cysts).
Thyroid ultrasoundThyroid nodules.
CT Imaging
Coronary artery calcium scoreCalcified plaque in heart arteries; refines heart attack risk.
Low-dose chest CTEarly lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.
MRI Imaging
Brain MR angiographyAneurysms and narrowed brain arteries.
Abdominal MRI / MRCPLiver, pancreas and bile duct tumors and disease.
Brain MRIBrain tumors, small strokes, aneurysms and early degeneration.
Breast MRIBreast cancer in high-risk women.
Pelvic MRIPelvic organ abnormalities.
Whole spine MRIWhole spine survey.
Endoscopy
ColonoscopyColon polyps and colorectal cancer; polyps can usually be removed during the same exam.
Gastroscopy (upper GI endoscopy)Stomach and esophagus ulcers, inflammation and cancer.
NasopharyngoscopyNasopharyngeal and throat abnormalities.
Women's Health
HPV DNA testHigh-risk HPV strains that cause cervical cancer.
Bone & Body Composition
Bone density (DXA)Osteoporosis and fracture risk.
Eye
General eye examOverall eye examination.
ENT & Dental
Hearing testHearing loss.
ENT examinationEar, nose and throat abnormalities.
Neuro & Cognitive
Autonomic nervous system (HRV) testStress and autonomic balance.
Consultation
Physician physical examinationA doctor's hands-on examination and history taking.
Physician consultation and report reviewA doctor explains your results and what to do next.
Vitals
Body composition analysis
Body fat, muscle mass and water percentage.
Blood Count
Complete blood count
Anemia, infection and blood cell disorders.
Liver Function
Albumin
Liver function and nutrition status.
Alkaline phosphatase
Liver, bile duct and bone conditions.
ALT (SGPT)
Liver cell damage; the most common liver screening test.
AST (SGOT)
Liver cell damage.
Direct bilirubin
Bile duct obstruction.
Gamma-GT
Bile duct and alcohol-related liver stress.
Globulin and A/G ratio
Immune protein levels.
Lipase
Pancreatic enzyme; more specific than amylase for pancreatitis.
Total bilirubin
Jaundice, liver and bile problems.
Kidney & Electrolytes
Blood urea nitrogen
Kidney function.
Creatinine
Kidney function.
Estimated GFR
Kidney filtering capacity; stages chronic kidney disease.
Uric acid
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
Total cholesterol / HDL ratio
A calculated ratio of total cholesterol to HDL cholesterol used in some cardiovascular risk calculators.
HDL cholesterol
Protective cholesterol level.
High-sensitivity CRP
Inflammation linked to heart disease risk.
LDL cholesterol
The main cholesterol driving heart disease risk.
Total cholesterol
Cardiovascular risk.
Triglycerides
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucose
Diabetes and prediabetes.
Hemoglobin A1c
Average blood sugar over the past three months; diabetes.
Fasting insulin
Insulin resistance.
Thyroid & Endocrine
DHEA-S
Adrenal androgen level.
Female hormone panel (FSH, LH, E2)
Menopause status and hormone balance.
Free T4
Thyroid hormone level.
Testosterone
Male hormone level; low testosterone.
TSH
Thyroid function; the primary thyroid screening test.
Vitamin D (25-OH)
Vitamin D deficiency; bone health.
Tumor Markers
AFP
Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125
Ovarian cancer marker.
CA 19-9
Pancreatic and biliary cancer marker.
CEA
Colorectal and other GI cancer marker.
PSA
Prostate cancer marker.
Infection Serology
Hepatitis B surface antibody
Immunity to hepatitis B (from vaccine or past infection).
Hepatitis C antibody
Hepatitis C infection.
Hepatitis B surface antigen
Current hepatitis B infection; very common in Taiwan.
Urine & Stool
Urinalysis
Kidney disease, urinary infection, diabetes.
Cardiac
Resting ECG
Heart rhythm and signs of prior heart damage.
Pulmonary
Lung function test
Asthma, COPD and lung capacity.
Ultrasound
Abdominal ultrasound
Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasound
Breast lumps; complements mammography, especially in dense breasts.
Carotid ultrasound
Plaque in the neck arteries; stroke risk.
Liver elastography (FibroScan)
Liver scarring and fat without a biopsy.
Pelvic (gynecologic) ultrasound
Uterus and ovary abnormalities (fibroids, cysts).
Thyroid ultrasound
Thyroid nodules.
CT Imaging
Coronary artery calcium score
Calcified plaque in heart arteries; refines heart attack risk.
Low-dose chest CT
Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.
MRI Imaging
Brain MR angiography
Aneurysms and narrowed brain arteries.
Abdominal MRI / MRCP
Liver, pancreas and bile duct tumors and disease.
Brain MRI
Brain tumors, small strokes, aneurysms and early degeneration.
Breast MRI
Breast cancer in high-risk women.
Pelvic MRI
Pelvic organ abnormalities.
Whole spine MRI
Whole spine survey.
Endoscopy
Colonoscopy
Colon polyps and colorectal cancer; polyps can usually be removed during the same exam.
Gastroscopy (upper GI endoscopy)
Stomach and esophagus ulcers, inflammation and cancer.
Nasopharyngoscopy
Nasopharyngeal and throat abnormalities.
Women's Health
HPV DNA test
High-risk HPV strains that cause cervical cancer.
Bone & Body Composition
Bone density (DXA)
Osteoporosis and fracture risk.
Eye
General eye exam
Overall eye examination.
ENT & Dental
Hearing test
Hearing loss.
ENT examination
Ear, nose and throat abnormalities.
Neuro & Cognitive
Autonomic nervous system (HRV) test
Stress and autonomic balance.
Consultation
Physician physical examination
A doctor's hands-on examination and history taking.
Physician consultation and report review
A doctor explains your results and what to do next.
Also listed: Beta-hCG, H. pylori test (gastroscopy), Liquid-based Pap smear, Low-residue meal replacement for colonoscopy, Peripheral arterial stiffness test, SHBG (sex hormone-binding globulin), Small dense LDL (sdLDL). And 2 further items the hospital lists only in Chinese.

Before you book

SedationAvailable
Bowel prepRequired
If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
Beitou Health Management Hospital
District hospital
Taipei · Beitou

On the OCAC i僑卡 partner list. Card holders can ask the center about a discount.

12 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Extra costs
  • For sedated GI endoscopy, consumables and polyp removal are charged separately from the package price.

    Source ↗ · checked 2026-09-20

Booking and payment
  • For this package, payment in full by bank transfer is required before the checkup.

    Source ↗ · checked 2026-09-20

  • For this package, payment is made by bank transfer before the checkup.

    Source ↗ · checked 2026-09-20

  • For general check-in, the center accepts any one of: ID card, National Health Insurance card, driver's license, passport, or resident certificate.

    Source ↗ · checked 2026-09-20

Before and on the day
  • For the standard health checkup, patients must begin fasting, including water and chewing gum, from midnight the night before the checkup.

    Source ↗ · checked 2026-09-20

  • Patients on medication for chronic conditions such as hypertension, cardiovascular disease or diabetes are asked to stop taking them the morning of the checkup (except an asthma inhaler) and to bring the medication to take after all exams are done.

    Source ↗ · checked 2026-09-20

  • Patients who are pregnant or may be pregnant are asked to tell the technicians directly so they can be excluded from X-ray exams and Pap tests.

    Source ↗ · checked 2026-09-20

  • Patients scheduled for an intraocular pressure test are asked not to wear contact lenses on the day of the exam.

    Source ↗ · checked 2026-09-20

  • Patients are asked to bring a stool sample with them to the checkup.

    Source ↗ · checked 2026-09-20

Ask your own doctor before changing any medicine.

Results
  • A specialist physician explains the checkup results one-on-one on the same day.

    Source ↗ · checked 2026-09-20

  • Checkup reports are delivered electronically through the app and by email; a paper copy costs extra.

    Source ↗ · checked 2026-09-20

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$13,130–17,407 for a woman (63 of 65 tests) and US$11,580–15,739 for a man (58 of 60 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Radiation from this package's imaging

About 3.2 mSv from the tests we could identify, a typical adult dose for these exams: roughly 1.1 years of natural background radiation (about 3 mSv a year, US average).

This package also lists 9 items we have not matched to a test; if any of them is an X-ray, CT or PET scan, the total is higher.

  • Bone density (DXA) · about less than 0.01 mSv
  • Coronary artery calcium score · about 1.7 mSv
  • Low-dose chest CT · about 1.5 mSv

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 28 of these tests
Recommended (grade A/B)The USPSTF recommends screening all adults aged 18 to 79 years for hepatitis C virus infection. (2020) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for hearing loss in adults 50 years or older. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in postmenopausal women younger than 65 years who are at increased risk, based on a clinical risk-assessment tool. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for osteoporosis in men. (2025) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in women 65 years or older. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast ultrasound in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers ultrasound and MRI as supplemental tests; see mri_breast. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The recommendation states there are currently no accurate, validated biomarkers for early detection of pancreatic cancer and that the USPSTF does not recommend screening the general population by any method; it does not name CA 19-9. The D grade applies to screening this population by any method, not to CA 19-9 as a separately graded test. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Recommended against (grade D)The USPSTF recommends against screening for asymptomatic carotid artery stenosis in the general adult population. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years, including with colonoscopy every 10 years. (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years, including with colonoscopy every 10 years. (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Selective (grade C)The USPSTF recommends that clinicians selectively offer colorectal cancer screening, including with colonoscopy every 10 years, to adults aged 76 to 85 years based on overall health, prior screening history and the patient's preferences. (2021) · USPSTF ↗ Note: Grade C reflects an individual decision rather than a blanket recommendation for or against. Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding a coronary artery calcium score to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018; an update is in progress) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF has an update in progress specifically on coronary artery calcium scoring for enhanced cardiovascular risk assessment; the 2018 I statement remains the current final recommendation as of 2026-09-25.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Recommended (grade A/B)The USPSTF recommends screening for hepatitis B virus infection, with an HBsAg test followed by confirmatory testing, in adolescents and adults at increased risk for infection. (2020) · USPSTF ↗ Note: Risk groups include people born in a country with HBV prevalence of 2% or more, US-born people not vaccinated as infants whose parents were born in regions with very high HBV prevalence (8% or more), people with HIV, people who inject drugs, men who have sex with men, and household or sexual contacts of someone with HBV. The recommendation names regions by prevalence, not countries.
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women younger than 21 years. (2018; an update is in progress) · USPSTF ↗ Note: The D statements are against cervical cancer screening in these groups by any test, including HPV testing; see the matching pap_smear rows.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (CIN 2 or 3) or cervical cancer. (2018; an update is in progress) · USPSTF ↗ Note: The D statements are against cervical cancer screening in these groups by any test, including HPV testing; see the matching pap_smear rows.
Recommended (grade A/B)The USPSTF recommends screening for cervical cancer in women aged 30 to 65 years with high-risk HPV testing every 5 years, alone or combined with cytology, as an alternative to cytology alone. (2018; an update is in progress) · USPSTF ↗ Note: For women aged 21 to 29 the 2018 statement recommends cytology alone every 3 years, not HPV testing. A draft update posted December 10, 2024 proposes primary HPV testing every 5 years (clinician- or patient-collected) for ages 30 to 65, with cytology every 3 years or cotesting every 5 years as alternatives; not yet a final USPSTF recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening for cervical cancer in women older than 65 years who have had adequate prior negative screening and are not otherwise at high risk. (2018; an update is in progress) · USPSTF ↗ Note: The D statements are against cervical cancer screening in these groups by any test, including HPV testing; see the matching pap_smear rows.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding high-sensitivity CRP to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF lists an update in progress for this statement, but the key questions in its research plan cover coronary artery calcium scoring only, not hs-CRP.
Recommended (grade A/B)The USPSTF recommends annual screening for lung cancer with low-dose CT in adults aged 50 to 80 years with a 20 pack-year smoking history who currently smoke or quit within the past 15 years. (2021) · USPSTF ↗ Note: Screening should stop once the person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability to have curative lung surgery.
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The USPSTF does not recommend screening the general population for pancreatic cancer by any method; it mentions MRI only as one of the imaging methods studied in people at high risk. The D grade covers the pancreatic-cancer part of an abdominal MRI only, not the liver or bile duct parts of the scan. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast MRI in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers MRI and ultrasound as supplemental tests; see breast_ultrasound. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion) and does not address MRI screening for those groups.
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with transvaginal ultrasound. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers pelvic/transvaginal ultrasound and the CA-125 blood test; see ca125. This csv does not map pelvic_ultrasound to any recommendation about non-ovarian pelvic findings (fibroids, cysts), which the USPSTF does not address.
Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults. (2022) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for thyroid cancer in asymptomatic adults. (2017) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for bladder cancer in asymptomatic adults. (2011) · USPSTF ↗ Note: The USPSTF lists urine dipstick or microscopic urinalysis for hematuria (blood in the urine) among the bladder cancer screening tests it considered. This note covers only that use of a urinalysis.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for vitamin D deficiency in asymptomatic adults. (2021) · USPSTF ↗
General preparation notes for 22 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Body composition analysis

Mention when booking: Mention a pacemaker or implanted defibrillator: the test passes a weak electric current through the body and has traditionally not been recommended with these devices.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Fasting insulin

Usually needs 8 to 12 hours of fasting (no food or drink except plain water) beforehand.

Mention when booking: Mention biotin (vitamin B7) supplements, usually paused for at least a day before this test, and any diabetes medicine; ask the prescribing doctor before changing any medicine.

Urinalysis

Usually needs a clean-catch (midstream) sample; some tests instead ask you to collect all urine passed over 24 hours.

Mention when booking: Ask which specific urine test your provider ordered, since collection instructions vary by test.

Lung function test

Usually asks for no smoking for 24 hours, no heavy meals for at least 2 hours, and no alcohol for at least 4 hours beforehand; wear loose clothing.

Mention when booking: Mention a recent heart attack, stroke or surgery, a chest infection, heart problems or uncontrolled blood pressure; ask whether to bring or hold your usual inhaler.

Abdominal ultrasound

Usually needs about 6 hours without food beforehand; clear fluids other than milk or fizzy drinks are commonly still allowed. Loose, comfortable clothing is easiest.

Mention when booking: Mention if you have type 1 diabetes, so the center can offer an early appointment time.

Pelvic (gynecologic) ultrasound

For a transabdominal scan, drinking water beforehand to fill the bladder is common; for a transvaginal scan, an empty bladder is usual instead.

Mention when booking: Tell the center which type of scan you expect, and mention if you are, or might be, pregnant.

Coronary artery calcium score

Usually needs about 4 hours without food, caffeine or smoking beforehand; no contrast injection is used for this scan.

Mention when booking: Tell the center if pregnancy is possible.

Afterwards: No recovery time is needed; normal activities can usually resume right away.

Low-dose chest CT

Usually needs no fasting and no contrast injection; loose clothing with no metal is easiest.

Mention when booking: Tell the center if you are, or might be, pregnant.

Abdominal MRI / MRCP

Guidelines on eating vary by center; some ask for a short fast before an abdominal MRI or MRCP. Expect to hold your breath at times during the scan.

Mention when booking: Mention a pacemaker or other implanted device, metal fragments, pregnancy, kidney disease, or claustrophobia.

Afterwards: If you take a sedative for claustrophobia or anxiety, you'll need someone to take you home; arrange this before the scan.

Brain MR angiography

Guidelines on eating and drinking vary by center, so ask when booking. Remove jewelry and metal before the scan.

Mention when booking: Mention a pacemaker, aneurysm clip, cochlear implant or other implanted device, metal fragments, pregnancy, kidney disease, or claustrophobia.

Afterwards: If you take a sedative for claustrophobia or anxiety, you'll need someone to take you home; arrange this before the scan.

Brain MRI

Guidelines on eating and drinking vary by center, so ask when booking. Remove jewelry and metal beforehand.

Mention when booking: Mention a pacemaker, aneurysm clip, cochlear implant or other implanted device, metal fragments, pregnancy, kidney disease, or claustrophobia.

Afterwards: If you take a sedative for claustrophobia or anxiety, you'll need someone to take you home; arrange this before the scan.

Breast MRI

Guidelines on eating and drinking vary by center. Contrast is usually injected through an IV. Leave jewelry at home and wear loose, comfortable clothing.

Mention when booking: Mention breast implants, a pacemaker or other implanted device, metal fragments, pregnancy, kidney disease or dialysis, a contrast allergy, or claustrophobia.

Afterwards: If you take a sedative for claustrophobia or anxiety, you'll need someone to take you home; arrange this before the scan.

Pelvic MRI

Guidelines on eating vary by center; some ask for a short fast beforehand. Remove jewelry and metal; expect to hold your breath at times.

Mention when booking: Mention a pacemaker or other implanted device, metal fragments, pregnancy, kidney disease, or claustrophobia.

Afterwards: If you take a sedative for claustrophobia or anxiety, you'll need someone to take you home; arrange this before the scan.

Whole spine MRI

Guidelines on eating and drinking vary by center. Remove jewelry and metal beforehand; most orthopedic implants are safe.

Mention when booking: Mention a pacemaker, spinal hardware, or other implanted device, metal fragments, pregnancy, kidney disease, or claustrophobia.

Afterwards: If you take a sedative for claustrophobia or anxiety, you'll need someone to take you home; arrange this before the scan.

Colonoscopy

Usually needs a clear-liquid diet the day before and a split-dose bowel-cleansing prep taken the evening before and morning of the exam; drinking extra fluids helps avoid dehydration.

Mention when booking: Tell the center about heart, kidney or lung disease, blood thinners, diabetes medicine, aspirin, arthritis medicine or iron; ask the prescribing doctor before changing any medicine.

Afterwards: After sedation, no driving, operating machinery or signing legal documents for the rest of the day; someone should take you home.

Gastroscopy (upper GI endoscopy)

Usually needs about 8 hours without food or drink, including water, beforehand.

Mention when booking: Tell the center about heart or lung disease, aspirin, blood thinners, arthritis medicine, insulin or iron, and ask the prescribing doctor before changing any medicine.

Afterwards: After sedation, no driving, machinery or legal documents that day; get a ride home. Contact a doctor for fever, trouble swallowing, chest or belly pain, or black stools; bleeding can start days later.

HPV DNA test

Usually needs no special preparation; if combined with a Pap test, avoiding sex, douching and vaginal products for 2 days beforehand is common.

Mention when booking: Tell the center if you are menstruating or had recent intercourse; the test can usually still be done.

Afterwards: Light spotting afterward is common and usually stops within a few hours.

Bone density (DXA)

Usually asks that you skip calcium supplements for 24 hours beforehand. Avoid clothing with metal zippers or buttons, and remove jewelry.

Mention when booking: Mention any recent barium exam or CT/nuclear-medicine contrast, and whether pregnancy is possible.

Hearing test

Usually needs no special preparation; expect to listen for tones or words through headphones, and sometimes a small probe checks how the eardrum moves.

Sources
As published by the hospital · checked 2026-09-20

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
High Precision Medical Imaging Health Checkup (B)
US$4,655
Book this checkup

If this isn't quite right

Other packages at Beitou Health Management Hospital

PackageTestsPrice
Cognitive Function Assessment Program (Dementia Screening)Taiwan nationals only49
US$1,420
NT$45,580
Vitality ProgramTaiwan nationals only54
US$2,645
NT$84,890
New Oxygen ProgramTaiwan nationals only59
US$3,074
NT$98,680
High Precision Medical Imaging Health Checkup (D)55
US$3,438
NT$110,357
Diamond ProgramTaiwan nationals only68
US$3,581
NT$114,950
High Precision Medical Imaging Health Checkup (C)59
US$3,996
NT$128,284
Xingjian All-Round Program (Companion Package)Taiwan nationals only41
US$4,050
NT$129,990
Deluxe ProgramTaiwan nationals only76
US$4,315
NT$138,520
Xingjian Prestige ProgramTaiwan nationals only49
US$5,077
NT$162,980
High Precision Medical Imaging Health Checkup (A)74
US$5,610
NT$180,076

All packages at Beitou Health Management Hospital →

Similar packages in Taipei

All checkups in Taipei →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Cancer screening · Heart and blood vessels · Stomach and colon · Women's health · All checkups in Taipei · What a checkup costs in Taiwan